Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01431196
Recruitment Status : Completed
First Posted : September 9, 2011
Last Update Posted : May 19, 2016
Spanish Clinical Research Network - CAIBER
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Marta Santisteban, Clinica Universidad de Navarra, Universidad de Navarra

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2012
  Actual Study Completion Date : December 2013